Calculation on Interaction between Ozone and Carrier to Form Ozonic Compound

Abstract:

It has some encouraging results to use ozone in medicaments, treatments and so on. As it is usually in gas state, unstable and strong oxidability, ozone is difficult to be stored and used commonly. It is the key matter in use of ozone commonly or conveniently that the carrier material and preparation response conditions are studied to make the bond strength between ozone and carrier to be felicitous and with the proper velocity to release ozone from the ozonic compound. Ozonic compound and related single molecules were calculated to study the interaction between ozone and carrier to form ozonic compound. The carrier and ozonic compound are designed from the calculations. The stability of the ozonic compound, or the bond strength between ozone and carrier are controlled felicitously to release ozone from the ozonic compound with proper velocity. Ozone antimicrobial can be composed and used conveniently, especially for common families. There are some characteristics of ozone antimicrobial or ozone, such as universal applicability, efficiency and rapidity, security, strong penetrability, no drug resistance and sterilization and treatment simultaneity.

• Periodical: Advanced Materials Research (Volumes 179-180)
• Pages: 490-495
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.179-180.490
• Online since: January 2011
• Authors: Xin Min Min, Hong Fei Liu
• Keywords: Calculation, Carrier Material, Design, Ozone Compound, Stability

References

[1] V. Travagli, I. Zanardi, A. Silvietti and V. Bocci: Int. J. Biological Macromolecules Vol. 41(2007), p.504.

DOI: 10.1016/j.ijbiomac.2007.06.010

[2] V. Bocci: Archives of Medical Research Vol. 37(2006), p.425.

[3] V. Bocci: Ozone-A New Medical Drug (Kluwer Academic Publishers, Netherlands 2005).

[4] V. Bocci: Oxygen-Ozone Therapy: A Critical Evaluation (Kluwer Academic Publishers, Netherlands 2002).

[5] G. Valacchi and V. Bocci: Mediators of Inflammation Vol. 9 (2000), p.271.

[6] A.I. Muminov and N. Khushvakova: Vestn-Otorinolaringol Vol. 6 (2002), p.46.

[7] H.J. Li, K.S. Geng and C.P. Wu: Int. Medicine and Health Guidance News Vol. 13 (2007) p.4.

[8] L. Tylicki, B. Biedunkiewicz and T. Nieweglowski: Artif Organs Vol. 28 (2004), p.234.

[9] C.F. Andreula, L. Simonetti and F. Santis: AJNR Am. J. Neuroradiol Vol. 24 (2003) p.996.

[10] V. Bocci: Mediators of Inflammation Vol. 3 (1994) p.315.

[11] D.E. Ellis and D. Guenzburger: Adv. Quantum Chem. Vol. 34 (1999) p.51.

[12] R. Criegee: Angew. Chem. Vol. 87 (1975), p.765.